Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population-based time-series analysis.

Addiction
Tony AntoniouTara Gomes

Abstract

In June 2016, the Ontario, Canada government implemented the Ontario Naloxone Program for Pharmacies (ONPP), authorizing pharmacists to provide injectable naloxone kits at no charge to all Ontario residents. In March 2018, the program was amended to include intranasal naloxone and remove the requirement to present a government health card to the dispensing pharmacist. We examined whether these changes increased naloxone dispensing through the ONPP. Population-based time-series analysis using interventional autoregressive integrated moving average models. Ontario, Canada. All Ontario residents between 1 July 2016 and 31 March 2020. Monthly rates of pharmacy naloxone dispensing. Overall, 199 484 individuals were dispensed a naloxone kit during the study period. In the main analysis, the rate of pharmacy naloxone dispensing increased by 65.1% following program changes (55.6-91.8 kits per 100 000 population between February 2018 and May 2018; P = 0.01). In subgroup analyses, naloxone dispensing increased among individuals receiving opioid agonist therapy (OAT) (3374.9-7264.2 kits per 100 000 OAT recipients; P = 0.04) among individuals receiving other prescription opioids (192.8-381.8 kits per 100 000 population prescribed opioids; ...Continue Reading

References

Dec 2, 2000·The International Journal on Drug Policy·J StrangM Gossop
Sep 8, 2006·Journal of Addictive Diseases·Sarz MaxwellSuzanne Carlberg-Racich
Jun 24, 2008·Substance Use & Misuse·Tinka Markham PiperSandro Galea
Apr 14, 2009·American Journal of Public Health·Maya Doe-SimkinsPeter Moyer
Sep 18, 2012·Journal of Substance Abuse Treatment·Alexander Y WalleyAl Ozonoff
Nov 15, 2012·JAMA : the Journal of the American Medical Association·Leo BeletskyAlexander Y Walley
Oct 31, 2015·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Lisham AshrafiounGloria Baciewicz
Mar 8, 2016·The International Journal on Drug Policy·Suzanne Nielsen, Marie Claire Van Hout
Oct 18, 2016·Injury Epidemiology·Rebecca E GiglioCharles J DiMaggio
Apr 22, 2017·Drug and Alcohol Review·Sarah M BagleyAlexander Y Walley
May 10, 2017·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jason W BusseGordon H Guyatt
Apr 27, 2018·Journal of Addiction Medicine·Tara GomesDavid N Juurlink
Aug 9, 2019·MMWR. Morbidity and Mortality Weekly Report·Gery P GuyChristopher M Jones
Dec 18, 2019·Healthcare Quarterly·Tara Gomes, David N Juurlink

❮ Previous
Next ❯

Software Mentioned

SAS Enterprise Guide

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.